Harm reduction: Moving through the third decade

References 

1. Advisory Council on the Misuse of Drugs . Report. AIDS and drug misuse. Part 1. London: Her Majesty's Stationary Office; 1988;
2. Albert ER, Byrne J. Coexisting or conjoined: The growth of the International drug users’ movement through participation with IHRA conferences. International Journal of Drug Policy. 2010;21(2):110–111
3. Ashton JR, Seymour H. Public health and the origins of the Mersey Model of harm reduction. International Journal of Drug Policy. 2010;21(2):94–96
4. Atun R, Kazatchkine M. The global fund's leadership on harm reduction: 2002–09. International Journal of Drug Policy. 2010;21(2):103–106
5. Ball, A., Beg, M., Doupe, A., & Weiler, G. (Eds.) (2005). World Health Organization—Evidence for Action for HIV Prevention, Treatment and Care among Injecting Drug Users. International Journal of Drug Policy, 16(Suppl. 1).
6. Barrett D. Security, development and human rights: Normative, legal and policy challenges for the international drug control system. International Journal of Drug Policy. 2010;21(2):140–144
7. Bergenstrom A, McLeod RS, Sharma M, Mesquita F, Dorabjee J, Atun R, et al. How much will it cost? Estimation of resource needs and availability for HIV prevention, treatment and care for people who inject drugs in Asia. International Journal of Drug Policy. 2010;21(2):107–109
8. Bridge J. Route transition interventions: Potential public health gains from reducing or preventing injecting. International Journal of Drug Policy. 2010;21(2):125–128
9. Bruce RD. Methadone as HIV prevention: High volume methadone sites to decrease HIV incidence rates in resource limited settings. International Journal of Drug Policy. 2010;21(2):122–124
10. Chatterjee A, Sharma M. Moving from a project to programmatic response: Scaling up harm reduction in Asia. International Journal of Drug Policy. 2010;21(2):134–136
11. Cook, C., Bridge, J., & Stimson, G. V. (2010). The diffusion of harm reduction in Europe and beyond. In T. Rhodes (Ed.), Harm reduction: Evidence, impacts and challenges, Scientific Monograph Series No 10. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction. Office for Official Publications of the European Communities.
12. Cook C, Kanaef N. Global state of harm reduction 2008: Mapping the response to drug-related HIV and hepatitis C epidemics. London: International Harm Reduction Association; 2008;
13. Des Jarlais DC. Learning from HIV epidemics among injecting drug users. International Journal of Drug Policy. 2010;21(2):97–99
14. Erickson P, Hathaway AD. Normalization and harm reduction: Research avenues and policy agendas. International Journal of Drug Policy. 2010;21(2):137–139
15. Gartner C, Hall W. Harm reduction policies for tobacco users. International Journal of Drug Policy. 2010;21(2):129–130
16. Haemmig, R. (2009). Personal communication.
17. International Harm Reduction Association . What is harm reduction? A position statement from the International Harm Reduction Association. London: International Harm Reduction Association; 2009;
18. International Harm Reduction Association and Human Rights Watch . Building consensus: A reference guide to human rights and drug policy. London: International Harm Reduction Association; 2009;
19. Institute of Medicine . Preventing HIV infection among injecting drug users in high risk countries: An assessment of the evidence. Washington, DC: The National Academies Press; 2006;
20. Islam MM, Day CA, Conigrave KM. Harm reduction healthcare: From an alternative to the mainstream platform?. International Journal of Drug Policy. 2010;21(2):131–133
21. Kamarulzaman A, Saifuddeen SM. Islam and harm reduction. International Journal of Drug Policy. 2010;21(2):115–118
22. Maguet O, Majeed M. A challenge for the future: Introducing and scaling up harm reduction in Afghanistan, the worldwide opium supplier. International Journal of Drug Policy. 2010;21(2):119–121
23. Mathers M, Cook C, Degenhardt L. Improving the data to improve the global response to HIV among people who inject drugs. International Journal of Drug Policy. 2010;21(2):100–102
24. Merkinaite S, Grund JP, Frimpong A. Young people and drugs: Next generation of harm reduction. International Journal of Drug Policy. 2010;21(2):112–114
25. Michels I, Stover H. Harm reduction—From a conceptual framework to practical experience: The example of Germany. Substance use und misuse special edition on interventions, policies and evidence: Taking an experimental look at international drug control. 2009;
26. Newcombe R. High time for harm reduction. Druglink. 1987;2(1):10–11
27. Rhodes, T., Hartnoll, R., & Johnson, A. (1991). Out of the agency and on to the streets: A review of HIV outreach health education in Europe and the United States. London: Institute for the Study of Drug Dependence, Research Monograph 2.
28. UNAIDS . Intensifying HIV prevention: UNAIDS policy position paper. 2005;http://data.unaids.org/publications/irc-pub06/jc1165-intensif_hiv-newstyle_en.pdf
29. United Nations General Assembly (2006). Resolution 60/262, Political declaration on HIV/AIDS, A/RES/60/262. Available online at: http://www.un.org/ga/president/62/issues/hiv/N0550332.pdf.
30. UNAIDS . Financial resources required to achieve universal access to HIV prevention, treatment, care and support. 2007;Available online at: http://data.unaids.org/pub/Report/2007/JC1678_Fin_Res_Req_en.pdf
31. United Nations Human Rights Council (2009). Resolution 12/27, The protection of human rights in the context of human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). UN Doc No A/HRC/RES/12/27, October 22, 2009.
32. Wodak, A. (2009). Personal communication.
33. World Health Organization . WHO, UNAIDS and UNODC: Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Geneva: WHO; 2009;